SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-010328
Filing Date
2020-08-11
Accepted
2020-08-11 16:14:48
Documents
73
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nviv-20200630x10q.htm 10-Q 1182719
2 EX-31.1 nviv-20200630ex311561db2.htm EX-31.1 14035
3 EX-31.2 nviv-20200630ex31206d619.htm EX-31.2 13743
4 EX-32.1 nviv-20200630ex321d5d09d.htm EX-32.1 7554
5 EX-32.2 nviv-20200630ex322b4c852.htm EX-32.2 7615
  Complete submission text file 0001558370-20-010328.txt   5883560

Data Files

Seq Description Document Type Size
6 EX-101.INS nviv-20200630.xml EX-101.INS 1278897
7 EX-101.SCH nviv-20200630.xsd EX-101.SCH 47308
8 EX-101.CAL nviv-20200630_cal.xml EX-101.CAL 43189
9 EX-101.DEF nviv-20200630_def.xml EX-101.DEF 170330
10 EX-101.LAB nviv-20200630_lab.xml EX-101.LAB 431550
11 EX-101.PRE nviv-20200630_pre.xml EX-101.PRE 327960
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37350 | Film No.: 201092582
SIC: 3841 Surgical & Medical Instruments & Apparatus